BSE filing, NSE: VIDHIING. Summary written from the filing by ALFA Finder's alert engine.
Vidhi Specialty Food Ingredients Ltd: key numbers
- Share price
- ₹310.30
- Market cap
- ₹1,550 Cr
- Revenue (annual)
- ₹380.0 Cr
- Net profit (annual)
- ₹48.96 Cr
- P/E (TTM)
- 25.7×Sector 28.2×
- Promoter holding
- 64.27%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vidhi Specialty Food Ingredients Ltd
All →Vidhi Specialty Food Ingredients Earnings Call Transcript: Key Takeaways
Vidhi reported strong revenue growth driven by trading volume, while manufacturing margins remained stable despite geopolitical disruptions.
Vidhi Specialty Food Ingredients Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs.136.5 Cr (+82% YoY), PAT Rs.17.6 Cr (+66.9%), EBITDA margin 19.3% (down ~430bps YoY). Strategy centres on tablet coatings (Coat Icon) and capacity expansion.
Vidhi Specialty Food Ingredients Management Change
Mr. Ashit K. Doshi resigned as Independent Director of Vidhi Specialty Food Ingredients Ltd on October 26, 2026, citing personal reasons. He exited Audit and N&R Committees.
Vidhi Specialty Food Ingredients Q2 FY27 Results: Net Profit ₹17.6 Cr, Up 66.0% YoY
Vidhi Specialty Food Ingredients Ltd reported revenue from operations of ₹136.5 Cr (+82.0% YoY) and net profit of ₹17.6 Cr (+66.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.6 Cr · +66.0% YoY
Vidhi Specialty Food Ingredients Board Meeting Date
Vidhi Specialty Food Ingredients intimated a board meeting on 26 Oct 2026 to consider unaudited Q2 FY27 results. No financial figures are disclosed in this advance intimation.
Vidhi Specialty Food Ingredients Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Other business update announcements
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years
Msafe Equipments Business Update
MSAFE Equipments announced a Dhanteras puja at its upcoming Mathura integrated manufacturing facility, expected to commence operations by May 2027. The release describes planned capacity expansion but reports no contract, order, or financial value.
Skyways Air Services Business Update
Skyways Air Services renewed its Global Annual Agreement with Qatar Airways for one year. The agreement's size is not quantifiable, so no value is assigned.
- From
- Qatar Airways Group Q.C.S.C.
- Execution
- 1 year from effective date 1 January 2026
Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.